A Purdue University team has discovered a new therapeutic target for triple-negative breast cancer. The research, led by Kyle ...

Antal and Yeo, who also are members of UCSD’s Moores Cancer Center, say the key to targeting triple-negative breast cancer, or TNBC, is managing a protein called poly (U)-binding splicing factor 60, ...

Announcing a new publication for Acta Materia Medica journal. Single-cell RNA sequencing (scRNA-seq) data from published datasets were obtained to investigate the expression and dysregulation of ...

The recent discovery of glycoRNAs on the cell surface upended the world of cell biology. These glycoRNAs were found to form ...

The interaction between RNA-binding proteins (RBPs) and circular RNAs (circRNAs) has emerged as a key area of interest in understanding cancer biology. As critical regulators of gene expression, RBPs ...

The process by which glycoRNAs are created and deployed to the cell surface has been identified by Boston Children’s Hospital researchers.

The interaction between circular RNA (circRNA) and RNA-binding protein (RBP). Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that ...

A novel study from Korea uncovers the process of synthesis and pivotal role of the transfer RNA-derived fragment, 5′-tRH-GlyGCC, in cancer progression. By interacting with splicing factors, it ...

An international research team has succeeded in deciphering a key mechanism that controls the growth of pancreatic cancers.

Pancreatic cancer may evade the immune system not by accident but by actively switching off internal danger signals through ...